Activating a non-CIPU Technical Unit with Transfer of Energy Sample Clauses

Activating a non-CIPU Technical Unit with Transfer of Energy. The provisions included in this article only apply to those markets specified in the Rules governing Transfers of Energy in a market situation with Transfer of Energy. In case of an activation of Demand Flexibility by an FSP, the following rules apply with regard to [BRP]’s Balancing Perimeter. These rules are based on the principles for adjusting Balancing Perimeters described in Point 12 of the Rules governing Transfers of Energy: o If [BRP] is not associated with this FSP, its Balancing Perimeter is adjusted on a quarter-hourly basis throughout the activation with the Delivered Volume of Flexibility, aggregated at the level of the Balancing Perimeter and aggregated on a quarter-hourly basis. The Delivered Volume of flexibility at a Delivery Point is based on the principles relating to the calculation of the Delivered Volume of flexibility, as set out in section 11 of the Transfer of Energy Rules. If the FSP delivers a larger volume than that requested by Xxxx, the individual Delivered Volume of Flexibility at a Delivery Point, based on the aforementioned rules and totalled across all Delivery Points involved in the delivery of flexibility pro rata to the sum of the individual Delivered Volumes of Flexibility at all relevant Delivery Points, is adjusted so that the total Delivered Volume of Flexibility, totalled across all Delivery Points involved in the delivery of flexibility, is equal to Elia’s Ordered Volume of Flexibility. o If [BRP] is associated with this FSP, in its capacity as BRPfsp, its Balancing Perimeter is adjusted by the difference between the Delivered Volume and the Ordered Volume, aggregated at the level of the Balancing Perimeter and aggregated on a quarter-hourly basis. In this way, the difference between the Delivered Volume and the Ordered Volume of Flexibility is allocated, on a quarter-Hourly basis, to the Balancing Perimeter of [BRP] as BRPfsp, to which the Tariff for Imbalances is applied. The Delivered Volume of flexibility at a Delivery Point is based on the principles relating to the calculation of the Delivered Volume of flexibility, as set out in section 11 of the Transfer of Energy Rules. If the FSP delivers a larger volume than that requested by Xxxx, the individual Delivered Volume of Flexibility at a Delivery Point, based on the aforementioned rules and totalled across all Delivery Points involved in the delivery of flexibility pro rata to the sum of the individual Delivered Volumes of Flexibility at all relevant Delive...
AutoNDA by SimpleDocs

Related to Activating a non-CIPU Technical Unit with Transfer of Energy

  • DISTRIBUTION OF CONTRACTOR PRICE LIST AND CONTRACT APPENDICES Contractor shall provide Authorized Users with electronic copies of the Contract, including price lists and Appendices, upon request. Contract Updates will be handled as provided in Appendix C – Contract Modification Procedures.

  • Manufacturing Technology Transfer Upon AbbVie’s written request with respect to a given Collaboration CAR-T Product and Licensed Product, Caribou shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party Provider) of all Materials and Know-How Controlled by Caribou relating to the then-current process for the Manufacture of such Collaboration CAR-T Product and any corresponding Licensed Products (each, a “Manufacturing Process”). Caribou shall provide, shall cause its Affiliates to provide, and shall use Commercially Reasonable Efforts to assist AbbVie in causing all Third Party Providers to provide, all reasonable assistance requested by AbbVie to enable AbbVie (or its Affiliate or designated Third Party Provider, as applicable) to implement each Manufacturing Process at the facilities designated by AbbVie. If requested by AbbVie, such assistance shall include facilitating the entering into of agreements with applicable Third Party suppliers relating to such Collaboration CAR-T Product and any corresponding Licensed Products. Without limitation of the foregoing, in connection with the Manufacturing Process and related transfer: (a) Caribou shall, and shall cause its Affiliates to, make available to AbbVie (or its Affiliate or designated Third Party Provider, as applicable), and shall use Commercially Reasonable Efforts to assist AbbVie in causing all Third Party Providers to make available to AbbVie, from time to time as AbbVie may request, all Materials and Manufacturing-related Know-How Controlled by Caribou relating to each Manufacturing Process, including methods, reagents and processes and testing/characterization Know-How, and all documentation constituting material support, performance advice, shop practice, standard operating procedures, specifications as to Materials to be used, and control methods, that are necessary or reasonably useful to enable AbbVie (or its Affiliate or designated Third Party manufacturer, as applicable) to use and practice such Manufacturing Process; (b) Caribou shall cause all appropriate employees and representatives of Caribou and its Affiliates, and shall use Commercially Reasonable Efforts to assist AbbVie in causing all appropriate employees and representatives of Third Party Providers, to meet with employees or representatives of AbbVie (or its Affiliate or designated Third Party Provider, as applicable) at the applicable manufacturing facility at mutually convenient times to assist with the working up and use of each Manufacturing Process and with the training of the personnel of AbbVie (or its Affiliate or designated Third Party Provider, as applicable) to the extent necessary or reasonably useful to enable AbbVie (or its Affiliate or designated Third Party Provider, as applicable) to use and practice such Manufacturing Process; (c) Without limiting the generality of this Section 4.4.2, Caribou shall cause all appropriate analytical and quality control laboratory employees and representatives of Caribou and its Affiliates, and shall use Commercially Reasonable Efforts to assist AbbVie in causing all appropriate analytical and quality control laboratory employees and representatives of Third Party Providers, to meet with employees or representatives of AbbVie (or its Affiliate or designated Third Party Provider, as applicable) at the applicable manufacturing facility and make available all necessary equipment, at mutually convenient times, to support and execute the provision of all applicable analytical methods and the validation thereof (including all applicable Know-How, Information and Materials Controlled by Caribou, and sufficient supplies of all primary and other reference standards); (d) Caribou shall, and shall cause its Affiliates to, take such steps, and shall use Commercially Reasonable Efforts to assist AbbVie in causing Third Party Providers take such steps, as are necessary or reasonably useful to assist AbbVie (or its Affiliate or designated Third Party Provider, as applicable) in obtaining any necessary licenses, permits or approvals from Regulatory Authorities with respect to the Manufacture of the applicable Collaboration CAR-T Products and corresponding Licensed Products at the applicable facilities; and (e) Caribou shall, and shall cause its Affiliates to, provide, and shall use Commercially Reasonable Efforts to assist AbbVie in causing Third Party Providers to provide, such other assistance as AbbVie (or its Affiliate or designated Third Party Provider, as applicable) may reasonably request to enable AbbVie (or its Affiliate or designated Third Party Provider, as applicable) to use and practice each Manufacturing Process and otherwise to Manufacture the applicable Collaboration CAR-T Products and corresponding Licensed Products.

  • COMMENCEMENT OF WORK UNDER A SOW AGREEMENT Commencement of work as a result of the SOW-RFP process shall be initiated only upon issuance of a fully executed SOW Agreement and Purchase Order.

  • Dissemination of Research Findings and Acknowledgement of Controlled-Access Datasets Subject to the NIH GDS Policy

  • Certification Regarding Prohibition of Boycotting Israel (Tex Gov. Code 2271)

  • Agreement Xxx 0000 The Company shall not produce iron ore under this Agreement for transportation in any calendar year in excess of the approved production limit nor shall the total number of the mine workforce exceed the approved mine workforce without the prior consent in principle of the Minister and, subject to that consent, approval of detailed proposals in regard thereto in accordance with this Clause.

  • Drug Free Work Place Grantee shall establish and maintain a drug-free work place policy.

  • MSAA Indicator Technical Specification Document This Agreement shall be interpreted with reference to the MSAA Indicator Technical Specifications document.

  • Manufacturing License Subject to the terms of this Agreement, including without limitation Section 2.2, Theravance grants to GSK an exclusive license under the Theravance Patents and Theravance Know-How to make and have made API Compound or formulated Alliance Product in the Territory.

  • End User License Agreement This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. xxxx://xxxxxxxxxxxxxxx.xxx/licenses/by-nc-nd/3.0/ You are free to: Share: to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!